Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Hamlet BioPharma

7.13 SEK

+2.15 %

Less than 1K followers

HAMLET B

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hamlet BioPharma

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)6.506.507.743.752.694.144.13
Shares101.6106.4106.4114.9116.4167.8177.7
Market cap660.1691.0823.1431.1313.7694.5733.0
Enterprise value649.5677.7815.7391.5295.3671.5722.2
EV/S-------
EV/EBITDAneg.neg.neg.neg.neg.neg.neg.
EV/EBITneg.neg.neg.neg.neg.neg.neg.
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B82.2165.96298.8911.3414.6310.3717.96
P/S-------
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio71.1 %72.0 %21.6 %91.1 %74.0 %94.2 %84.9 %
Gearing ratio-------
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.